stage iii uterine corpus cancer
Showing 1 - 13 of 13
Lymphedema, Stage 0 Cervical Cancer, Stage 0 Uterine Corpus Cancer Trial in Philadelphia (Management of Therapy Complications,
Terminated
- Lymphedema
- +18 more
- Management of Therapy Complications
- Quality-of-Life Assessment
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jun 11, 2021
Malignant Female Reproductive System Tumor, Malignant Hepatobiliary Tumor, Partner Trial in New Brunswick (Cognitive Behavior
Completed
- Malignant Female Reproductive System Neoplasm
- +38 more
- Cognitive Behavior Therapy
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 7, 2021
Stage I Breast Cancer, Stage I Cervical Cancer, Stage I Ovarian Cancer Trial in Philadelphia, Reading (Informational
Completed
- Stage I Breast Cancer
- +38 more
- Informational Intervention
-
Philadelphia, Pennsylvania
- +1 more
Feb 20, 2018
Prognostic Biomarkers in Patients With Endometrial Cancer
Completed
- Endometrial Adenocarcinoma
- +5 more
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Aug 22, 2017
Collecting Tumor Samples From Patients With Gynecological Tumors
Completed
- Borderline Ovarian Clear Cell Tumor
- +85 more
- Laboratory Biomarker Analysis
-
Fayetteville, Arkansas
- +186 more
Oct 26, 2016
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Endometrioid Adenocarcinoma, Variant With Squamous
Completed
- Endometrial Adenocarcinoma
- +7 more
- Laboratory Biomarker Analysis
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Mar 17, 2016
Tumor Tissue Samples From Stage III, Stage IV, or Recurrent
Not yet recruiting
- Recurrent Uterine Corpus Carcinoma
- +2 more
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jun 3, 2015
Response in Tissue Samples From Patients With Endometrial Cancer
Not yet recruiting
- Stage I Uterine Corpus Cancer
- +3 more
- Laboratory Biomarker Analysis
- Study of Socioeconomic and Demographic Variables
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
May 27, 2015
Biomarkers in Samples From Patients With Endometrial Cancer
Not yet recruiting
- Lynch Syndrome
- +5 more
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
May 27, 2015
Blood and Tissue Samples From Patients With Uterine Cancer
Not yet recruiting
- Endometrial Serous Adenocarcinoma
- +4 more
- Diagnostic Laboratory Biomarker Analysis
- +5 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
May 27, 2015
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in Philadelphia
Completed
- Endometrial Adenocarcinoma
- +5 more
- Doxorubicin Hydrochloride
- +4 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Apr 30, 2015
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Philadelphia
Completed
- Endometrial Adenocarcinoma
- +4 more
- Doxorubicin Hydrochloride
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Dec 29, 2014
Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage III Uterine Corpus Cancer Trial in Philadelphia
Completed
- Endometrial Clear Cell Adenocarcinoma
- +3 more
- Paclitaxel
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Dec 29, 2014